Tilman Schmidt

540 total citations
18 papers, 384 citations indexed

About

Tilman Schmidt is a scholar working on Immunology, Pathology and Forensic Medicine and Nephrology. According to data from OpenAlex, Tilman Schmidt has authored 18 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Pathology and Forensic Medicine and 3 papers in Nephrology. Recurrent topics in Tilman Schmidt's work include Psoriasis: Treatment and Pathogenesis (5 papers), T-cell and B-cell Immunology (4 papers) and IL-33, ST2, and ILC Pathways (3 papers). Tilman Schmidt is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (5 papers), T-cell and B-cell Immunology (4 papers) and IL-33, ST2, and ILC Pathways (3 papers). Tilman Schmidt collaborates with scholars based in Germany, Russia and United Kingdom. Tilman Schmidt's co-authors include Christian F. Krebs, Ulf Panzer, Jan-Hendrik Riedel, Hans‐Joachim Paust, Oliver M. Steinmetz, Rolf A.K. Stahl, Jan‐Eric Turner, Anett Peters, Hans‐Willi Mittrücker and Joachim Velden and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Tilman Schmidt

17 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tilman Schmidt Germany 8 259 105 96 72 52 18 384
Andreas Perniok Germany 11 260 1.0× 233 2.2× 59 0.6× 105 1.5× 61 1.2× 15 478
Shunhua Guo United States 12 179 0.7× 138 1.3× 67 0.7× 68 0.9× 32 0.6× 22 371
Scott Henderson United States 5 235 0.9× 207 2.0× 118 1.2× 29 0.4× 22 0.4× 7 374
Julie Milojevic Switzerland 6 157 0.6× 61 0.6× 102 1.1× 27 0.4× 25 0.5× 9 359
Haitao Yu China 8 200 0.8× 232 2.2× 18 0.2× 66 0.9× 17 0.3× 13 378
Punchong Hanvivadhanakul Thailand 7 305 1.2× 359 3.4× 46 0.5× 58 0.8× 10 0.2× 11 481
Carlos Horacio Muñoz‐Vahos Colombia 10 111 0.4× 151 1.4× 24 0.3× 127 1.8× 21 0.4× 21 286
Ana Molina Spain 8 157 0.6× 63 0.6× 49 0.5× 90 1.3× 19 0.4× 9 326
Nora P. Goette Argentina 14 62 0.2× 80 0.8× 26 0.3× 121 1.7× 65 1.3× 30 485
Thitima Benjachat Thailand 8 209 0.8× 177 1.7× 83 0.9× 148 2.1× 19 0.4× 9 359

Countries citing papers authored by Tilman Schmidt

Since Specialization
Citations

This map shows the geographic impact of Tilman Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Schmidt more than expected).

Fields of papers citing papers by Tilman Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilman Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Schmidt. The network helps show where Tilman Schmidt may publish in the future.

Co-authorship network of co-authors of Tilman Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Tilman Schmidt. A scholar is included among the top collaborators of Tilman Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilman Schmidt. Tilman Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shiferaw, Kirubel Biruk, et al.. (2026). Sex and Gender Differences in Chronic Kidney Disease—Explained by the Brenner–Luyckx Concept of Hyperfiltration. Journal of Clinical Medicine. 15(4). 1654–1654.
2.
Wolf, Robert H., et al.. (2024). Complement Activation in Nephrotic Glomerular Diseases. Biomedicines. 12(2). 455–455. 2 indexed citations
3.
Stracke, Sylvia, et al.. (2023). Geschlechtsunterschiede in der ambulanten Versorgung von Menschen mit chronischer Nierenkrankheit. 19(1). 34–40. 1 indexed citations
4.
Schmidt, Tilman & Tobias B. Huber. (2023). Thrombotische Mikroangiopathien. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 118(1). 14–20. 2 indexed citations
5.
Schmidt, Tilman, et al.. (2022). Cervical radiculopathy. SHILAP Revista de lepidopterología. 14(5). 103–108. 2 indexed citations
6.
Schmidt, Tilman, et al.. (2022). An Interdisciplinary Diagnostic Approach to Guide Therapy in C3 Glomerulopathy. Frontiers in Immunology. 13. 826513–826513. 3 indexed citations
7.
Pischke, Sven, Julian Schulze zur Wiesch, Munif Haddad, et al.. (2021). Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General. Pathogens. 11(1). 18–18. 3 indexed citations
8.
Schmidt, Tilman, Matthias B. Schulze, Sigrid Harendza, & Elion Hoxha. (2020). Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab. Journal of Nephrology. 34(2). 603–606. 10 indexed citations
9.
Evdoshenko, E. P., et al.. (2019). Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects». SHILAP Revista de lepidopterología. 11(4). 172–175. 4 indexed citations
10.
Krohn, Sonja, Jasper F. Nies, Tilman Schmidt, et al.. (2018). IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation. Journal of the American Society of Nephrology. 29(4). 1210–1222. 58 indexed citations
11.
Schmidt, Tilman, et al.. (2018). Mechanisms and functions of IL-17 signaling in renal autoimmune diseases. Molecular Immunology. 104. 90–99. 13 indexed citations
12.
Evdoshenko, E. P., М. Н. Захарова, N A Malkova, et al.. (2018). Provision of alemtuzumab safety is one of the main components of pharmacovigilance. S S Korsakov Journal of Neurology and Psychiatry. 118(8). 82–82. 4 indexed citations
13.
Schmidt, Tilman, et al.. (2018). CLIPPERS syndrome. Neurology neuropsychiatry Psychosomatics. 10(2). 76–82. 1 indexed citations
14.
Алифирова, В. М., М. Н. Захарова, Elena Zakharova, et al.. (2017). Clinical recommendations on the use of alemtuzumab (lemtrada). S S Korsakov Journal of Neurology and Psychiatry. 117(2. Vyp. 2). 115–115. 7 indexed citations
15.
Krebs, Christian F., Tilman Schmidt, Jan-Hendrik Riedel, & Ulf Panzer. (2017). T helper type 17 cells in immune-mediated glomerular disease. Nature Reviews Nephrology. 13(10). 647–659. 83 indexed citations
16.
Schmidt, Tilman, Hans‐Joachim Paust, Christian F. Krebs, et al.. (2014). Function of the Th17/Interleukin‐17A Immune Response in Murine Lupus Nephritis. Arthritis & Rheumatology. 67(2). 475–487. 75 indexed citations
17.
Krebs, Christian F., Hans‐Joachim Paust, Tilman Schmidt, et al.. (2013). MicroRNA-155 Drives TH17 Immune Response and Tissue Injury in Experimental Crescentic GN. Journal of the American Society of Nephrology. 24(12). 1955–1965. 36 indexed citations
18.
Paust, Hans‐Joachim, Jan‐Eric Turner, Jan-Hendrik Riedel, et al.. (2012). Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney International. 82(1). 72–83. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026